PEPID

What's New in PEPID 16.0

 

Update NowThe latest update is now available for:

PEPID Nursing Suites

Professional Nursing, Critical Care Nursing, Oncology Nursing, Gerontological Nursing

Medical/Nursing Content:

New, expanded or updated medical monographs in the following systems:

  • Allergy & Immunology
    • Angioedema
  • Dermatology
    • Melanoma
    • Psoriasis
  • FDEENT
    • Nasolacrimal Duct Obstruction
  • Gastroenterology
    • Acute Viral Hepatitis
    • Crohn's Disease
    • Irritable Bowel Syndrome
  • Hematology/Oncology
    • Cancer-related Nausea and Vomiting
    • Prostate Cancer
  • Infectious Disease
    • AIDS Treatment: Antiretroviral Drugs
    • Ebola
  • Metabolic/Endocrine
    • Diabetes Type II: Drug Therapeutics
    • Hyperphosphatemia
    • Obesity: Therapeutics
      • General
      • Diet
      • Pharmacotherapy
      • Surgery
    • Vitamin D Deficiency
  • Neurology
    • 2014 AHA/ASA Secondary Stroke Prevention Guidelines
    • Craniosynostosis
    • Ischemic CVA
    • Multiple Sclerosis
  • Obstetrics/Gynecology
    • Diagnosis of Pregnancy
    • Intrauterine Device (IUD)
    • Vaginal Delivery
  • Orthopedics
    • Anterior Cruciate Ligament
    • Developmental Dysplasia of the Hip
    • Epicondylitis
    • Femoral Neck Fracture
    • Ligamentous Injuries of the Knee: General
    • Transient Synovitis
  • Pediatrics
    • Bacterial Meningitis
      • Empiric Therapy
    • Craniosynostosis
    • Developmental Dysplasia of the Hip
    • Nasolacrimal Duct Obstruction
    • Transient Synovitis
  • Psychiatry/Addiction
    • Alcohol Abuse: Screening & Diagnosis
    • Bipolar Disorder
    • Recognizing Addiction
    • Schizophrenia
  • Renal/Urology
    • Chronic Kidney Disease
  • Respiratory
    • Idiopathic Pulmonary Fibrosis
    • Pulmonary Hypertension
    • Upper Respiratory Infections (Adult)
  • Miscellaneous
    • Diet/Nutrition and Disease Prevention
    • Pain Management: Opioids

New, expanded or updated nursing considerations in the following medical monographs:

  • Ebola
  • Urinary Tract Infection (UTI)

New, expanded or updated nursing considerations in the following drug monographs:

  • Propantheline

New or updated evidence-based practice:

  • Evidence-Based Practice Inquiries
  • Clinical Inquiries
  • PURLs
  • U.S. Preventive Services Task Force Recommendations
Drugs:
  • 32 new drugs:
    • Abacavir/Dolutegravir/Lamivudine
    • Belinostat
    • Blinatumomab
    • Canagliflozin/Metformin
    • Ceftolozane/Tazobactam
    • Cobicistat
    • Conjugated estrogens/Bazedoxifene
    • Dapagliflozin/Metformin
    • Dulaglutide
    • Eliglustat
    • Elvitegravir
    • Empagliflozin
    • Filgrastim-sndz
    • Fluocinolone (Ophthalmic)
    • Idelalisib
    • Insulin Human (Inhaled)
    • Ledipasvir/Sofosbuvir
    • Naloxegol
    • Naltrexone/Bupropion
    • Netupitant/Palonosetron
    • Nivolumab
    • Olaparib
    • Olodaterol
    • Oritavancin
    • Peginterferon beta-1a
    • Pembrolizumab
    • Pirfenidone
    • Suvorexant
    • Sulfur Hexafluoride lipid-type A microspheres
    • Tavaborole
    • Tedizolid phosphate
    • Testosterone Nasal
  • New indications/dosing forms for:
    • Aflibercept
    • Apixaban
    • Budesonide
    • Dantrolene
    • Denosumab
    • Enzalutamide
    • Hydrocodone
    • Ibrutinib
    • Ivermectin
    • Liraglutide
    • Pasireotide
    • Ramucirumab
    • Sotalol
  • Dosing updates and changes:
    • Argatroban
    • Bosutinib
    • Interferon beta-1a
    • Ipilimumab
    • Vandetanib
Special Update:
  • The U.S. Food and Drug Administration has approved the first biosimilar product, Filgrastim-sndz (Zarxigo), in the United States. Filgrastim-sndz is biosimilar to Filgrastim (Neupogen).
    • Biosimilar — A biological product that is approved based on a showing that it is highly similar to an already-approved biological product, known as a reference product. The biosimilar also must show it has no clinically meaningful differences in terms of safety and effectiveness from the reference product. Only minor differences in clinically inactive components are allowable in biosimilar products. (FDA)
Drug Interactions Generator:

Interactions for new and existing drugs added

Medical Calculators:

ADAM (Androgen Deficiency in the Aging Male) Calculator


 

PEPID RN Student Clinical Companion

Medical/Nursing Content:

NANDA Content: 2015-2017 Edition

  • New Diagnoses:
    • Frail Elderly Syndrome
    • Risk For Frail Elderly Syndrome
    • Risk For Overweight
    • Overweight
    • Obesity
    • Chronic Functional Constipation
    • Risk For Chronic Functional Constipation
    • Impaired Sitting
    • Impaired Standing
    • Risk For Decreased Cardiac Output
    • Risk For Impaired Cardiovascular Function
    • Impaired Mood Regulation
    • Impaired Emancipated Decision-Making
    • Readiness For Enhanced Emancipated Decision-Making
    • Risk For Impaired Emancipated Decision-Making
    • Risk For Corneal Injury
    • Risk For Impaired Oral Mucous Membrane
    • Risk For Pressure Ulcer
    • Risk For Delayed Surgical Recovery
    • Risk For Impaired Tissue Integrity
    • Risk For Urinary Tract Injury
    • Labile Emotional Control
    • Risk For Hypothermia
    • Risk For Perioperative Hypothermia
    • Chronic Pain Syndrome
    • Labor Pain
  • Revised Diagnoses:
    • Ineffective Breastfeeding
    • Interrupted Breastfeeding
    • Readiness For Enhanced Breastfeeding
    • Excess Fluid Volume
    • Impaired Physical Mobility
    • Risk For Caregiver Role Strain
    • Spiritual Distress
    • Risk For Imbalanced Body Temperature
    • Hyperthermia
    • Hypothermia
    • Delayed Surgical Recovery
    • Impaired Tissue Integrity
    • Acute Pain
    • Chronic Pain
  • Revised Labels/Titles:
    • Ineffective Self-Health Management is now Ineffective Health Management
    • Readiness For Enhanced Self-health Management is now Readiness For Enhanced Health Management
    • Ineffective Family Therapeutic Regimen Management is now Ineffective Family Health Management
    • Impaired Individual Resilience is now Impaired Resilience
    • Risk For Compromised Resilience is now Risk For Impaired Resilience
  • Removed/Retired Diagnoses:
    • Disturbed Energy Field
    • Adult Failure To Thrive
    • Readiness For Enhanced Immunization Status
    • Imbalanced Nutrition: More Than Body Requirements
    • Risk For Imbalanced Nutrition: More Than Body Requirements
    • Impaired Environmental Interpretation Syndrome
    • Delayed Growth And Development

New, expanded or updated medical monographs in the following systems:

  • Allergy & Immunology
    • Angioedema
  • Dermatology
    • Melanoma
    • Psoriasis
  • FDEENT
    • Nasolacrimal Duct Obstruction
  • Gastroenterology
    • Acute Viral Hepatitis
    • Crohn's Disease
    • Irritable Bowel Syndrome
  • Hematology/Oncology
    • Cancer-related Nausea and Vomiting
    • Prostate Cancer
  • Infectious Disease
    • AIDS Treatment: Antiretroviral Drugs
    • Ebola
  • Metabolic/Endocrine
    • Diabetes Type II: Drug Therapeutics
    • Hyperphosphatemia
    • Obesity: Therapeutics
      • General
      • Diet
      • Pharmacotherapy
      • Surgery
    • Vitamin D Deficiency
  • Neurology
    • 2014 AHA/ASA Secondary Stroke Prevention Guidelines
    • Craniosynostosis
    • Ischemic CVA
    • Multiple Sclerosis
  • Obstetrics/Gynecology
    • Diagnosis of Pregnancy
    • Intrauterine Device (IUD)
    • Vaginal Delivery
  • Orthopedics
    • Anterior Cruciate Ligament
    • Developmental Dysplasia of the Hip
    • Epicondylitis
    • Femoral Neck Fracture
    • Ligamentous Injuries of the Knee: General
    • Transient Synovitis
  • Pediatrics
    • Bacterial Meningitis
      • Empiric Therapy
    • Craniosynostosis
    • Developmental Dysplasia of the Hip
    • Nasolacrimal Duct Obstruction
    • Transient Synovitis
  • Psychiatry/Addiction
    • Alcohol Abuse: Screening & Diagnosis
    • Bipolar Disorder
    • Recognizing Addiction
    • Schizophrenia
  • Renal/Urology
    • Chronic Kidney Disease
  • Respiratory
    • Idiopathic Pulmonary Fibrosis
    • Pulmonary Hypertension
    • Upper Respiratory Infections (Adult)
  • Miscellaneous
    • Diet/Nutrition and Disease Prevention
    • Pain Management: Opioids

New, expanded or updated nursing considerations in the following medical monographs:

  • Ebola
  • Urinary Tract Infection (UTI)

New, expanded or updated nursing considerations in the following drug monographs:

  • Propantheline

New or updated evidence-based practice:

  • Evidence-Based Practice Inquiries
  • Clinical Inquiries
  • PURLs
  • U.S. Preventive Services Task Force Recommendations
Drugs:
  • 32 new drugs:
    • Abacavir/Dolutegravir/Lamivudine
    • Belinostat
    • Blinatumomab
    • Canagliflozin/Metformin
    • Ceftolozane/Tazobactam
    • Cobicistat
    • Conjugated estrogens/Bazedoxifene
    • Dapagliflozin/Metformin
    • Dulaglutide
    • Eliglustat
    • Elvitegravir
    • Empagliflozin
    • Filgrastim-sndz
    • Fluocinolone (Ophthalmic)
    • Idelalisib
    • Insulin Human (Inhaled)
    • Ledipasvir/Sofosbuvir
    • Naloxegol
    • Naltrexone/Bupropion
    • Netupitant/Palonosetron
    • Nivolumab
    • Olaparib
    • Olodaterol
    • Oritavancin
    • Peginterferon beta-1a
    • Pembrolizumab
    • Pirfenidone
    • Suvorexant
    • Sulfur Hexafluoride lipid-type A microspheres
    • Tavaborole
    • Tedizolid phosphate
    • Testosterone Nasal
  • New indications/dosing forms for:
    • Aflibercept
    • Apixaban
    • Budesonide
    • Dantrolene
    • Denosumab
    • Enzalutamide
    • Hydrocodone
    • Ibrutinib
    • Ivermectin
    • Liraglutide
    • Pasireotide
    • Ramucirumab
    • Sotalol
  • Dosing updates and changes:
    • Argatroban
    • Bosutinib
    • Interferon beta-1a
    • Ipilimumab
    • Vandetanib
Special Update:
  • The U.S. Food and Drug Administration has approved the first biosimilar product, Filgrastim-sndz (Zarxigo), in the United States. Filgrastim-sndz is biosimilar to Filgrastim (Neupogen).
    • Biosimilar — A biological product that is approved based on a showing that it is highly similar to an already-approved biological product, known as a reference product. The biosimilar also must show it has no clinically meaningful differences in terms of safety and effectiveness from the reference product. Only minor differences in clinically inactive components are allowable in biosimilar products. (FDA)
Drug Interactions Generator:

Interactions for new and existing drugs added

Medical Calculators:

ADAM (Androgen Deficiency in the Aging Male) Calculator


 

Pharmacist Pro with AHFS

New and Updated Medical Content:
  • Allergy & Immunology
    • Angioedema
  • Dermatology
    • Melanoma
  • Gastroenterology
    • Acute Viral Hepatitis
  • Neurology
    • Craniosynostosis
    • Multiple Sclerosis
  • Orthopedics
    • Epicondylitis
    • Transient Synovitis
  • Psychiatry
    • Alcohol Abuse: Screening & Diagnosis
    • Bipolar Disorder
    • Schizophrenia
Evidence-based Medicine:
  • 3 new clinical inquiries:
    • Is immediate-release topiramate an effective treatment for adult obesity?
    • Which risk factors and signs and symptoms are associated with coccidioidomycosis?
    • Do annual pelvic exams benefit asymptomatic women who receive regular Pap smears?
  • 3 new PURLs:
    • Prescribing statins for patients with ACS? No need to wait.
    • Helmets for positional skull deformities: A good idea, or not?
  • 3 new evidence-based practice inquiries:
    • Does head CT assist in the diagnosis of an adult with syncope?
    • Are behavioral therapies effective for ADHD?
    • What is the best evaluation for angioedema and urticaria?
    • Does the Mediterranean style diet decrease the risk of myocardial infarction, stroke, or death in patients at risk of cardiovascular disease?
Drugs:
  • New Monographs
    • Belinostat
    • Perampanel
    • Apremilast
    • Vilanterol
    • Vortioxetine
    • Albiglutide
    • Dapagliflozin
    • Nitroglycerin (Topical)
    • Luliconazole
    • Efinaconazole
    • Tavaborole
    • Tasimelteon
  • Revised Monographs
    • Sirolimus
    • Etanercept
    • Diclofenac (Topical)
    • Varenicline
    • Bendamustine
    • Golimumab
    • Tocilizumab
    • Dalfampridine
    • Ecallantide
    • Ustekinumab
    • Pegloticase
    • Lurasidone
    • Brentuximab
    • Vortioxetine
    • Testosterone
    • Cefazolin
    • Mometasone (Topical)
    • Interferon Beta (Systemic)
    • Doxepin (Topical)
    • Delavirdine
    • Eprosartan
    • Telmisartan
    • Eplerenone
    • Enfuvirtide
    • Tipranavir
    • Maraviroc
    • Nebivolol Hydrochloride
    • Guanfacine
    • Tapentadol
    • Azilsartan
    • Canagliflozin
    • Acetaminophen
    • Hydrocodone
    • Amiloride
    • Codeine
    • Oxycodone
    • Ibuprofen
    • Sodium Nitroprusside
    • Methyldopa
    • Clonidine
    • Prazosin
    • Hydralazine
    • Diazoxide
    • Clonazepam
    • Pentazocine
    • Triamterene
    • Chlorothiazide
    • Chlorthalidone
    • Metolazone
    • Nitroglycerin
    • Isosorbide (Systemic)
    • Hydrochlorothiazide
  • Revised Monographs, cont.
    • Propranolol
    • Minoxidil (Systemic)
    • Spironolactone
    • Nadolol
    • Antivenin (Latrodectus mactans) (Equine)
    • Dexamethasone (Systemic)
    • Hydrocortisone (Systemic)
    • Methylprednisolone
    • Ethacrynic Acid
    • Furosemide
    • Metoprolol
    • Aspirin
    • Timolol (Systemic)
    • Atenolol
    • Pindolol
    • Bumetanide
    • Indapamide
    • Labetalol
    • Acebutolol
    • Esmolol
    • Didanosine
    • Felodipine
    • Fosinopril
    • Quinapril
    • Lisinopril
    • Bisoprolol
    • Doxazosin
    • Terazosin
    • Betaxolol (Systemic)
    • Isradipine
    • Torsemide
    • Stavudine
    • Losartan
    • Tramadol
    • Moexipril
    • Saquinavir
    • Metformin
    • Indinavir
    • Ritonavir
    • Trandolapril
    • Nelfinavir
    • Carvedilol
    • Pioglitazone
    • Perindopril
    • Rosiglitazone
    • Eszopiclone
    • Liraglutide
    • Haloperidol
    • Naloxone
    • Triamcinolone (Systemic)
    • Betamethasone (Systemic)
    • Captopril
    • Enalapril
    • Buprenorphine
    • Benazepril
    • Ramipril
    • Simvastatin
    • Nisoldipine
    • Glimepiride
  • Discontinued Monographs
    • Tositumomab
    • Abarelix
    • Dextran
    • Urokinase
    • Tacrine
Special Update:
  • The U.S. Food and Drug Administration has approved the first biosimilar product, Filgrastim-sndz (Zarxigo), in the United States. Filgrastim-sndz is biosimilar to Filgrastim (Neupogen).
    • Biosimilar — A biological product that is approved based on a showing that it is highly similar to an already-approved biological product, known as a reference product. The biosimilar also must show it has no clinically meaningful differences in terms of safety and effectiveness from the reference product. Only minor differences in clinically inactive components are allowable in biosimilar products. (FDA)
Drug Interactions Generator:

Interactions for new and existing drugs added

Medical Calculators:

ADAM (Androgen Deficiency in the Aging Male) Calculator


 

AHFS Drug Information® by PEPID

Drugs:
  • New Monographs
    • Belinostat
    • Perampanel
    • Apremilast
    • Vilanterol
    • Vortioxetine
    • Albiglutide
    • Dapagliflozin
    • Nitroglycerin (Topical)
    • Luliconazole
    • Efinaconazole
    • Tavaborole
    • Tasimelteon
  • Revised Monographs
    • Clopidogrel
    • Varenicline
    • Bendamustine
    • Prasugrel
    • Lurasidone
    • Brentuximab
    • Testosterone
    • Cefazolin
    • Delavirdine
    • Enfuvirtide
    • Tipranavir
    • Maraviroc
    • Didanosine
    • Stavudine
    • Saquinavir
    • Indinavir
    • Ritonavir
    • Nelfinavir
    • Eprosartan
    • Telmisartan
    • Eplerenone
    • Nebivolol
    • Guanfacine
    • Azilsartan
    • Sodium Nitroprusside
    • Methyldopa
    • Clonidine
    • Prazosin
    • Hydralazine
    • Isosorbide
    • Propranolol
    • Minoxidil
    • Nadolol
    • Metoprolol
    • Rauwolfia Alkaloids
    • Nitrates and Nitrites General Statement
    • Timolol
    • Atenolol
    • Pindolol
    • Labetalol
    • Acebutolol
    • Esmolol
    • Felodipine
    • Fosinopril
    • Quinapril
    • Lisinopril
    • Bisoprolol
    • Doxazosin
    • Terazosin
    • Betaxolol
    • Isradipine
    • Losartan
    • Moexipril
  • Revised Monographs, cont.
    • Trandolapril
    • Carvedilol
    • Perindopril
    • Tapentadol
    • Acetaminophen
    • Hydrocodone
    • Codeine
    • Oxycodone
    • Ibuprofen
    • Clonazepam
    • Pentazocine
    • Aspirin
    • Opiate Agonists General Statement
    • Tramadol
    • Amiloride
    • Triamterene
    • Chlorothiazide
    • Chlorthalidone
    • Metolazone
    • Methyclothiazide
    • Hydrochlorothiazide
    • Bendroflumethiazide
    • Spironolactone
    • Ethacrynic Acid
    • Furosemide
    • Bumetanide
    • Indapamide
    • Torsemide
    • Canagliflozin
    • Diazoxide
    • Dexamethasone
    • Hydrocortisone
    • Methylprednisolone
    • Metformin
    • Pioglitazone
    • Rosiglitazone
    • Antivenin (Latrodectus mactans) (Equine)
    • Eszopiclone
    • Liraglutide
    • Haloperidol
    • Naloxone
    • Triamcinolone
    • Betamethasone
    • Captopril
    • Thiazides General Statement
    • Corticosteroids General Statement
    • Antineoplastic Agents General Statement
    • Salicylates General Statement
    • Enalapril
    • Buprenorphine
    • Benazepril
    • Ramipril
    • Simvastatin
    • Filgrastim, Tbo-filgrastim
    • Nisoldipine
    • Glimepiride
    • Immunobiologic Agents Available from the CDC
  • Discontinued Monographs
    • Tositumomab
    • Abarelix
    • Dextran
    • Urokinase
    • Tacrine
Drug Interactions Generator:

Interactions for new and existing drugs added

Medical Calculators:

ADAM (Androgen Deficiency in the Aging Male) Calculator


 

AHFS Drug Information Essentials® by PEPID

Drugs:
  • New Monographs
    • Belinostat
    • Perampanel
    • Apremilast
    • Vilanterol
    • Vortioxetine
    • Albiglutide
    • Dapagliflozin
    • Nitroglycerin (Topical)
    • Luliconazole
    • Efinaconazole
    • Tavaborole
    • Tasimelteon
  • Revised Monographs
    • Sirolimus
    • Etanercept
    • Diclofenac (Topical)
    • Varenicline
    • Bendamustine
    • Golimumab
    • Tocilizumab
    • Dalfampridine
    • Ecallantide
    • Ustekinumab
    • Pegloticase
    • Lurasidone
    • Brentuximab
    • Vortioxetine
    • Testosterone
    • Cefazolin
    • Mometasone (Topical)
    • Interferon Beta (Systemic)
    • Doxepin (Topical)
    • Delavirdine
    • Eprosartan
    • Telmisartan
    • Eplerenone
    • Enfuvirtide
    • Tipranavir
    • Maraviroc
    • Nebivolol Hydrochloride
    • Guanfacine
    • Tapentadol
    • Azilsartan
    • Canagliflozin
    • Acetaminophen
    • Hydrocodone
    • Amiloride
    • Codeine
    • Oxycodone
    • Ibuprofen
    • Sodium Nitroprusside
    • Methyldopa
    • Clonidine
    • Prazosin
    • Hydralazine
    • Diazoxide
    • Clonazepam
    • Pentazocine
    • Triamterene
    • Chlorothiazide
    • Chlorthalidone
    • Metolazone
    • Nitroglycerin
    • Isosorbide (Systemic)
    • Hydrochlorothiazide
  • Revised Monographs, cont.
    • Propranolol
    • Minoxidil (Systemic)
    • Spironolactone
    • Nadolol
    • Antivenin (Latrodectus mactans) (Equine)
    • Dexamethasone (Systemic)
    • Hydrocortisone (Systemic)
    • Methylprednisolone
    • Ethacrynic Acid
    • Furosemide
    • Metoprolol
    • Aspirin
    • Timolol (Systemic)
    • Atenolol
    • Pindolol
    • Bumetanide
    • Indapamide
    • Labetalol
    • Acebutolol
    • Esmolol
    • Didanosine
    • Felodipine
    • Fosinopril
    • Quinapril
    • Lisinopril
    • Bisoprolol
    • Doxazosin
    • Terazosin
    • Betaxolol (Systemic)
    • Isradipine
    • Torsemide
    • Stavudine
    • Losartan
    • Tramadol
    • Moexipril
    • Saquinavir
    • Metformin
    • Indinavir
    • Ritonavir
    • Trandolapril
    • Nelfinavir
    • Carvedilol
    • Pioglitazone
    • Perindopril
    • Rosiglitazone
    • Eszopiclone
    • Liraglutide
    • Haloperidol
    • Naloxone
    • Triamcinolone (Systemic)
    • Betamethasone (Systemic)
    • Captopril
    • Enalapril
    • Buprenorphine
    • Benazepril
    • Ramipril
    • Simvastatin
    • Nisoldipine
    • Glimepiride
  • Discontinued Monographs
    • Tositumomab
    • Abarelix
    • Dextran
    • Urokinase
    • Tacrine
Drug Interactions Generator:

Interactions for new and existing drugs added

Medical Calculators:

ADAM (Androgen Deficiency in the Aging Male) Calculator